This Cancer Drug Candidate Could Be a Hit for Pfizer
The FDA recently accepted the drugmaker's regulatory filing for review of a potential drug to treat a type of blood cancer.
The FDA recently accepted the drugmaker's regulatory filing for review of a potential drug to treat a type of blood cancer.